Table 2.
Baseline comparison of socio-demographic and clinical data*.
| Parameter | Details | hTNF | lTNF | (Comparison of means |
|---|---|---|---|---|
| (N hTNF/N lTNF) | (high PBMC TNF production group) | (low PBMC TNF production group) | as indicated in legend) | |
| Mean (sd) | Mean (sd) | p | ||
| Age | 43.47 (12.67) | 38.38 (12.46) | 0.086 | |
| Sex | male (36/37) | 13 (36.1%) | 11 (29.7%) | 0.80 |
| female (36/37) | 23 (63.9%) | 26 (70.3%) | ||
| BMI | 26.56 (5.74) | 26.69 (7.74) | 0.90 | |
| Family | in partnership (35/35) | 23 (65.7%) | 22 (62.9%) | 0.80 |
| married (35/36) | 11 (31.4%) | 11 (30.6%) | 0.79 | |
| with children (35/36) | 22 (62.9%) | 20 (55.6%) | 0.47 | |
| Education | secondary modern school (35/36) | 10 (28.6%) | 9 (25.0%) | 0.59 |
| junior high school (35/36) | 14 (40.00%) | 16 (44.4%) | 0.63 | |
| university-entrance diploma (35/36) | 11 (31.4%) | 11 (30.6%) | > 0.99 | |
| Diagnosis | F32.1 (36/37) | 35 (97.2%) | 36 (97.3%) | > 0.99 |
| F33.2 (36/37) | 1 (2.8%) | 1 (2.7%) | ||
| Weeks of mPT | 7.37 (2.34) | 6.73 (2.30) | 0.35 | |
| Medication | tranquilizer (36/37) | 2 (5.6%) | 0 (0.0%) | 0.15 |
| anti-depressants (36/37) | 15 (41.7%) | 10 (27.0%) | 0.077 | |
| neuroleptics (36/37) | 0 (0.0%) | 1 (2.7%) | 0.32 | |
| opiods (36/37) | 0 (0.0%) | 0 (0.0%) | – | |
| NSAR (36/37) | 4 (11.1%) | 3 (8.1%) | 0.69 | |
| anti-epileptics (36/37) | 2 (5.6%) | 3 (8.1%) | 0.64 | |
| other (36/37) | 20 (55.6%) | 15 (40.5%) | 0.23 |
*
Metric data were compared by Mann–Whitney U-test, ordinal data by Chi-X2-Test.